This activity is hosted on the site of our educational partner

You will be connecting to our educational partner, which controls its own content, practices, and other policies.

You will be connecting to our educational partner, which controls its own content, practices, and other policies.

  • Overview
  • Pre-Assessment
  • Activity
  • Post-Test
  • Evaluation
  • Claim Credit
Evidence to Practice Expert Roundtable: A Multidisciplinary Approach to Optimizing the Management of Psoriatic Arthritis

Evidence to Practice Expert Roundtable: A Multidisciplinary Approach to Optimizing the Management of Psoriatic Arthritis


Expert Perspective

Time to Complete

1 hour


April 15, 2019


April 15, 2020
Add to Queue

Maximum Credits

1.00 / AMA PRA Category 1 CreditTM
1.00 / CNE Contact Hour
1.00 / CE for Pharmacists (0.10 CEUs)

Accredited Provider

CME/CE Credit provided by the University of Cincinnati and AKH Inc., Advancing Knowledge in Healthcare

Activity is jointly-provided by AKH Inc., Advancing Knowledge in Healthcare and Tarsus Cardio dba South Beach Symposium

Commercial Supporter

This activity is supported by educational grants from Celgene Corporation and Novartis Pharmaceuticals Corporation.

Program Description

Psoriatic arthritis is a complex inflammatory disorder that requires multidisciplinary care in order to optimize outcomes. Because of related contributions of both skin and joint manifestations in the development, progression, and severity of PsA, enhanced collaboration between dermatologists and rheumatologists is necessary to optimize the diagnosis and treatment. Studies have shown that combined dermatology and rheumatology care can improve outcomes in patients with psoriasis and PsA, and this approach is being recognized as crucial to addressing common barriers that dermatologists and rheumatologists face in the management of this condition. This symposium overviewed the diagnosis, assessment, and treatment of patients with PsA, including advances in therapy, and practical tips on the multidisciplinary approach and collaboration between dermatologists and rheumatologists that is necessary to improve outcomes.

Intended Audience

This activity is designed to meet the needs of dermatologists, rheumatologists, nurses/nurse practitioners and residents who treat psoriatic arthritis.

Educational Objectives

Upon completion of the activity, participants should be better able to:

  • List practical tools designed to effectively screen or diagnose PsA in the dermatology and rheumatology setting
  • Define assessment strategies to evaluate PsA severity that incorporate both joint and skin manifestation in order to guide treatment
  • Develop individualized treatment strategies for patients with PsA based on the efficacy and safety of current and emerging pharmacotherapies
  • Identify effective methods for developing patient-centered care in order to improve adherence and overall outcomes in PsA patients

Conflict Of Interest Disclosure Policy

It is the policy of AKH Inc. to ensure independence, balance, objectivity, scientific rigor, and integrity in all of its continuing education activities. The faculty must disclose to the participants any significant relationships with commercial interests whose products or devices may be mentioned in the activity or with the commercial supporter of this continuing education activity. Identified conflicts of interest are resolved by AKH prior to accreditation of the activity and may include any of or combination of the following: attestation to non-commercial content; notification of independent and certified CME/CE expectations; referral to National Faculty Initiative training; restriction of topic area or content; restriction to discussion of science only; amendment of content to eliminate discussion of device or technique; use of other faculty for discussion of recommendations; independent review against criteria ensuring evidence support recommendation; moderator review; and peer review. AKH Inc., Advancing Knowledge in Healthcare, planners and reviewers have no relevant financial relationships to disclose.


Leon Kircik, MD
Associate Clinical Professor of Dermatology at Indiana University Medical Center
Medical Director at DermResearch, PLLC and Physicians Skin Care, PLLC in Louisville, Kentucky
Graduated with AOA Honors from State University of New York

Dr. Kircik discloses the following:
Advisory Board: Aclaris, Allergan, Inc., Almirall, Anacor Pharmaceuticals, Biogen-Idec, Colbar, Celgene, Cipher, Connetics Corporation, EOS, Exeltis, Ferndale, Laboratories, Inc., Foamix, Genentech, Inc., Intendis, Innocutis, Isdin, Johnson & Johnson, Nano Bio, OrthoNeutogena, Promius, Quinnova, SkinMedica, Inc., Stiefel Laboratories, Inc., Sun Pharma,, Valeant Pharmaceuticals Intl, Warner-Chilcott
Consultant: Allergan, Inc., Almirall, Amgen, Inc., Anacor Pharmaceuticals, Colbar, Cipher, CollaGenex, Connetics Corporation, Exeltis, Foamix, Genentech, Inc., Intendis, Isdin, Johnson & Johnson, Laboratory Skin Care Inc, LEO, Medical International Technologies, Merck, Merz, Novartis AG, OrthoNeutrogena, Promius, PuraCap, SkinMedica, Inc., Stiefel Laboratories, Inc., Sun Pharma, Taro, UCB, Valeant Pharmaceuticals, ZAGE
Contracted Research: Acambis, Allergan, Inc., Amgen, Inc., Anacor Pharmaceuticals, Astellas Pharma US, Inc., Asubio, Berlex Laboratories (Bayer HealthCare Pharmaceuticals),Biolive, Biopelle, Boehringer-Ingleheim, Breckinridge Pharma, Celgene, Centocor, Inc. Cellceutix, Coherus, CollaGenex, Combinatrix, Connetics Corporation, Coria, Dermavant, Dermira, Dow Pharmaceutical Sciences, Inc.,, DUSA, Eli Lilly, Exeltis, Ferndale Laboratories, Inc., Foamix, Genentech, Inc., GlaxoSmithKline, PLC, Healthpoint, LTD, Idera, Intendis, Innocutis, Johnson & Johnson, LEO, L’Oreal, 3MMaruho, Medicis Pharmaceutical Corp., Merck, Nano Bio, Novartis AG, Noven Pharmaceuticals, Nucryst Pharmaceuticals Corp, Obagi, Onset, OrthoNeutrogena, Promius, QLT, Inc.Quinnova, Quatrix, , PharmaDerm, Pfizer, SkinMedica, Inc., Stiefal Laboratories, Inc., Sun Pharma, TolerRX, UCB, Valeant Pharmaceuticals Intl, Warner-Chilcott, XenoPort

Mark G. Lebwohl, MD
Professor and Chairman of the Department of Dermatology of The Mount Sinai School of Medicine, the Manhattan Dermatologic Society and the New York State Society of Dermatology
Chairman of the Medical Board of the National Psoriasis Foundation
Mount Sinai Medical Center
New York, NY

Dr. Lebwohl discloses the following:
Consultant: Allergan, Aqua, Arcutis, Inc., Boehringer Ingelheim, Bristol Myers Squibb, Leo Pharma Menlo, Mitsubishi, Neuroderm, Promius, Theravance, Verrica

Joseph A. Markenson, MD
Rheumatologist with Hospital for Special Surgery
Memorial Sloan-Kettering Cancer Center
Graduate from State University of New York Downstate Medical Center College of Medicine
New York

Dr. Markenson has nothing to disclose.
Advisory Board and Speakers Bureau: Abbvie, Clegene, Jansen, Lilly, Novartis

Accredited Provider Disclosure

UC, AKH have nothing to disclose.

Publishing Staff Disclosures

UC, AKH & SBS have nothing to disclose.




AMA PRA Category 1 Credit(s)TM

Accreditation Statement

This Activity has been planned and implemented in accordance with the accreditation requirements and policies of the Accreditation Council for Continuing Medical Education (ACCME) through the joint providership of the University of Cincinnati and South Beach Symposium.

The University of Cincinnati is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.

Designation Statement

The University of Cincinnati designates this live activity for a maximum of 1.00 AMA PRA Category 1 CreditTM  .  Physicians should claim only the credits commensurate with the extent of their participation in the activity.

Physician Assistants
NCCPA accepts AMA PRA Category 1 CreditTM   from organizations accredited by ACCME.




CNE Contact Hour(s)

Accreditation Statement

AKH, Inc., Advancing Knowledge in Healthcare is accredited as a provider of continuing nursing education by the American Nurses Credentialing Center's Commission on Accreditation.

Designation Statement

This activity is awarded 1.00 Contact Hour.




CE for Pharmacists

Accreditation Statement

AKH Inc., Advancing Knowledge in Healthcare is accredited by the Accreditation Council for Pharmacy Education as a provider of continuing pharmacy education.

Designation Statement

AKH Inc., Advancing Knowledge in Healthcare approves this knowledge‐based activity for 1.00 contact hour (0.10 CEUs). UAN 0077-9999-19-015-H04-P. Initial release: April 15, 2019.

Disclosure of Unlabeled Use

This educational activity may include discussion of uses of agents that are investigational and/or unapproved by the FDA. Please refer to the official prescribing information for each product for discussion of approved indications, contraindications, and warnings.


This course is designed solely to provide the healthcare professional with information to assist in his/her practice and professional development and is not to be considered a diagnostic tool to replace professional advice or treatment. The course serves as a general guide to the healthcare professional, and therefore, cannot be considered as giving legal, nursing, medical, or other professional advice in specific cases. AKH Inc. specifically disclaim responsibility for any adverse consequences resulting directly or indirectly from information in the course, for undetected error, or through participant's misunderstanding of the content.


To obtain credit, a score of 70% or better on the post-test is required. This activity is offered at no cost to participants. Please proceed with the activity until you have successfully completed this program, answered all test questions, completed the post-test and evaluation, and have received a digital copy of your credit certificate. Your online certificate will be saved on myCME within your Profile/Exam History, which you can access at any time.

If you have any questions relating to the accreditation of this activity, please contact: Trish Brignoni,

Privacy Policy


Hardware and Software Requirements
  • A computer with an internet connection
  • Internet Browser: Internet Explorer 7.x or higher, Firefox 4.x or higher, Safari 2.x or higher, or any other W3C standards compliant browser
  • Additional Software: Adobe Flash Player and/or an HTML 5 capable browser maybe required for video or audio playback. PowerPoint or Adobe Acrobat Reader may occasionally be required
Add to Queue